학술논문

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, May 2021, 22(5):690-701)
Subject
Language
English
ISSN
14745488
14702045